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fied technique achieved significantly higher MVA
(2.19 ± 0.34 vs. 1.87 ± 0.96 cm2, p = 0.0001) with more
opened commissures (65% vs. 49.1%, p = 0.0001), and less
mitral regurgitation (30/243 vs. 77/381, p = 0.011). In long
term follow up, modified technique had significant lower
restenosis rate (9.46% vs. 23.88%, p = 0.0001), redo surgery
(2.88% vs. 7.34%, p = 0.029), and mitral valve area gain
loss (0.09 ± 0.04 vs. 0.27 ± 0.06 cm2, p = 0.0001). Kaplan–
Meier curve revealed no differences (hazard ratio = 1.04,
95% CI = 0.53 ± 2.01, p = 0.901) of total events (death, per-
foration, thrombo-embolism, atria-fibrillation, and large
ASD).
Conclusions: This study demonstrates the benefits
of applying bidirectional stepwise forces using modified
multi-track technique which resulted into higher post
dilation valve areas, less incidence of mitral regurgitation
and lower long term restenosis rate.
http://dx.doi:10.1016/j.jsha.2012.06.237
Impact of fenestration creation on managing
patients with protein losing enteropathy compli-
cating Fontan procedure
Mashail Alobaidan, Jasim Abdulhameed
Introduction: Protein losing enteropathy (PLE) is a
well known complication following Fontan procedure
and one way of managing such complication is to create
fenestration if it is not present or enlarging it if it is small
to reduce the Fontan pressure and reduce venous con-
gestion which end up by intestinal protein loss.
Aim: To evaluate the effect of such procedure in our
population.
Method: From February 2006 through October 2011,
9 patients who underwent fenestration creation due to
development of PLE were assessed in regard to clinical,
laboratory results and hemodynamic effect prior and
post-procedure.
Result: Median age is 7 years (4–21), median weight
is 23 kg (15–52), male:female ratio is 3.5:1 (male and 2
female), median saturation pre- and post-procedure
was 93% and 82%, respectively, median albumin pre-
and post-procedure was 18 g/dl and 31 g/dl during the
first 2 weeks and 36 g/dl thereafter, median pulmonary
artery pressure before and after was 25 mmHg (17–
32 mmHg) and 16 mmHg (14–19 mmHg), transpulmonary
pressure gradient reduced from a median of 11 mmHg to
5 mmHg, no immediate deaths, 2 patients need re-dilata-
tion, there was 2 (22%) late deaths (one has stent throm-
bosis 1 month after followed up by fulminant pulmonary
embolism, though all patients were on anticoagulant,
other one with sudden arrest came to the emergency
could not be resuscitated) 3 (33%) patients have persis-
tent low albumin though the fenestration is present in
patient.
Conclusion: Transcatheter fenestration creation as a
management of PLE following Fontan procedure is a fea-
sible procedure, can be done in the cath. lab with little
morbidity and mortality and with beneficial effect, how-
ever late complication and complete resolving of PLE is
of concern especially if done late.
http://dx.doi:10.1016/j.jsha.2012.06.238
Telephone intervention in chronic heart failure:
Quality project
May Al Khateeb
Background: Heart failure (HF) remains a serious
global health problem associated with poor quality of life,
diminished functional class and frequent hospital admis-
sions which leads to heavy personal, social, and economic
burdens. Nurse-based telephone interventions have
been associated with clear clinical benefits for patients
with HF, in the West; however, their effectiveness is
unknown in this region.
Objectives: Assess the effectiveness of telephone
intervention in patients with HF attending the Cardiovas-
cular Disease Management Program (CVDMP), King
Abdulaziz Cardiac Center (KACC).
Methods: This prospective, quality improvement
project assigned 40 consecutive patients with HF to stan-
dard care in the CVDMP and another 40 consecutive
patients with HF to standard care with the addition of a
telephone intervention. The telephone interview was car-
ried out weekly for 12 weeks inquiring about patient’s
current symptoms and educational reinforcing regarding
diet, exercise and medication adherence.
Patient’s symptoms, quality of life, ER visits and hos-
pitalization were followed over 3 months. Analysis will
be performed using SPSS Advanced Statistics for Win-
dows, version 18.
Results and conclusion: Pending.
http://dx.doi:10.1016/j.jsha.2012.06.239
Effect of adding a pill box on patient adherence to
medication in a Cardiovascular Disease Manage-
ment Program
May Al Khateeb
Background: Patient non-adherence to medication is
a major medical problem globally which leads to dimin-
ished quality of health outcomes and increased costs of
health care. Use of adherence aids, such as pill boxes
have been shown to increase medication adherence in
the West, however, no studies have been carried out in
Saudi Arabia.
Objectives: Assess the effectiveness of adding a pill
box to standard care provided in Cardiovascular Disease
Management Program (CVDMP) on patient adherence to
medication in King Abdulaziz Cardiac Center.
Methods: This prospective, quality improvement
project, randomly assigned 50 consecutive patients with
atherosclerosis to standard care in CVDMP and another
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50 consecutive patients to standard care with the addition
of a pill box. Medication adherence was measured using
the validated self-report tool Morisky Medication Adher-
ence Scale (MMAS) at baseline and 3 months follow-up.
Other variables collected included: heart rate, blood
pressure, blood glucose and New York Heart Association
(NYHA) functional class.
Analysis was performed using SPSS Advanced Statis-
tics for Windows, version 18.
Results and conclusion: Pending.
http://dx.doi:10.1016/j.jsha.2012.06.240
Early and late clinical outcome in elderly patients
after revascularization with Primary Percutaneous
Coronary Intervention presenting with acute ST-
elevation myocardial infarction: Results from
Qassim Primary Angioplasty Services (QAPAS)
registry
Mehboob Ali Dar, Akif Ali Mufti, Adil Azmy, Yasir
Beshir, Hassan Khalaf, Owayid Al Shammary,
Tariq I. Soomro, Akram Desoky, Mohammad
Abduzaher, Mohammad Sayed, Yasir Birema
Objectives: We sought to investigate the procedural
success rates, in hospital and 2 years clinical outcomes of
Primary Percutaneous Coronary Intervention in patients
older than 75 years presenting with acute myocardial
infarction.
Methods: Total of 50 patients, 75 years or older were
enrolled in the retrospective data analysis. Primary end-
points were procedural success, in hospital, short-term
(1 month) and long-term (2 years) all cause mortality.
Secondary end-points were recurrent MI, stroke, new
revascularization.
Results: Mean age was 80.5 ± 5.75 years (range 75–
96), 82% males, 18% females, 28 (56%) patients presented
with anterior wall MI, 19 (38%) with inferior wall MI and
2 (4%) had posterior wall MI. All underwent PPCI achiev-
ing a door to balloon time of 140 ± 50 min (range 52–
227 min) and CAG revealed SVD 16.5%, 2VD 29%, 3VD
54% and involvement of left main in 14.5% of cases. A
total of 68 stents were deployed, mean stent length of
33.29 mm using DES in 42 patients (85.5%) and BMS in
2 patients (4%). Thirty (60%) patients received Glycopro-
tein IIbIIIa inhibitors. Successful recanalization of IRA
was achieved in 90% of patients with 82% achieving TIMI
III flow while no reflow occurred in 2 patients. Procedure
related coronary artery dissection occurred in 2 patients.
Mechanical complications like severe MR and severe LV
dysfunction were observed in 4% and 16% of the cases,
respectively. One patient had a massive fatal haemopty-
sis. In-hospital mortality was 18%. One-month and
2 years mortality were 2.5% (n = 1) and 11% (n = 4),
respectively. Older age, Gp IIb IIIa use and higher Killip
Class were associated with higher overall mortality. The
incidence of recurrent MI and repeat revascularization
was 4% and 7%, respectively.
Conclusions: Our data reveal that in elderly patients
primary PCI is a feasible revascularization strategy and
such patients have a high in-hospital mortality and com-
plication rates.
http://dx.doi:10.1016/j.jsha.2012.06.241
Comparison between endothelial progenitor cell
capture and bare metal stents in coronary artery
disease patients at high risk for instent restenosis
and thrombosis
Mohamad Medhat El-Najjar, Hesham Boshra
Mahmoud, Yasser Ahmed Abdel Hady, Wael
Mohamad El-Najjar
Backgroud: Since EPCs represent a pool of cells
which contribute to the endothelial repair after vascular
injury, the increased homing and retention of these cells
at the site of stent implantation may increase and speed
up the process of endothelialization.
The new bioengineered stent with the immobilized
antibody against CD34 antigen bound to the surface of
the struts is thought to enable the stent to capture circu-
lating EPCs from the blood stream to establish a func-
tional endothelial lining preventing platelet adhesion
and activation, and thus thrombus formation, with mod-
ulation of the foreign body inflammatory response
through acceleration of the natural healing process, thus
preventing ISR. This may minimize the need for long
term dual anti-platelet therapy.
Objectives: The purpose of this study was to com-
pare the efficacy of the new endothelial progenitor cell
(EPC) capture stents with that of bare metal stents in cor-
onary artery disease patients at high risk for instent
restenosis and thrombosis.
Methods: We randomly assigned 38 patients with
lesions carrying a high risk of restenosis to have the Gen-
ous stent or a bare metal stent implanted. Lesions were
considered high risk of restenosis if one of the following
applied: a chronic coronary artery occlusion; a coronary
artery stenosis with a length of more than 20 mm; a lesion
in a coronary artery with a diameter of less than 2.8 mm
by QCA; or any lesion in a diabetic patient or renal
failure.
Results: At 6 months, the rate of the primary end
point, composite of ISR and IST, was 26% in the Genous
stent group when compared with 58% in the bare metal
stent group [p = 0.049]. Also, no stent thrombosis was
observed in the Genous stent group compared to 1 prob-
able stent thromboses in the bare metal stent group
(p = 0.3). The cumulative rate of MACE (cardiac death,
MI and clinically driven TLR) at 6 months was 26% in
the Genous stent group (all due to clinically driven
TLR) when compared with 52% in the bare metal stent
group, a difference due to clinically driven target lesion
revascularization (p-value = 0.1).
Conclusions: In patients with lesions carrying a high
risk of restenosis, the Genous stent resulted in a non-sig-
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